Lumexa Imaging (LMRI) CFO awarded 54,054 RSUs with price targets

Rhea-AI Filing Summary

Lumexa Imaging Holdings, Inc. reported that its Chief Financial Officer, Martin James Anthony, received two grants of common-stock-based compensation on December 12, 2025. Each grant covers 27,027 restricted stock units (RSUs) at a price of $0 per share, for a total of 54,054 RSUs now beneficially owned directly.

One RSU grant vests in three roughly equal annual installments on each of the first three anniversaries of the grant date, as long as he remains with the company. The second grant vests in three equal parts if the stock reaches volume-weighted average price targets of $27.00, $36.00 and $45.00 over any 60‑trading‑day period within up to four years, also subject to continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Martin James Anthony

(Last) (First) (Middle)

4200 SIX FORKS ROAD

SUITE 1000

(Street)

RALEIGH NC 27609

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lumexa Imaging Holdings, Inc. [ LMRI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		A		27,027(1)	A	$0	27,027	D
Common Stock	12/12/2025		A		27,027(2)(3)	A	$0	54,054	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock ("Common Stock"). The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer.

2. Represents RSUs, each one of which represents the contingent right to receive one share of Common Stock. The RSUs will vest in three substantially equal installments upon the attainment of three prescribed stock price targets of $27.00, $36.00 and $45.00 per share, which targets are measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period and continuing until the three-year anniversary of the grant date (the "First Vesting Date"), subject to the Reporting Person's continued service with the Issuer through the First Vesting Date. [continues in footnote 3]

3. [continued from footnote 2] If any of the stock price targets have not been achieved as of the First Vesting Date, then the remaining unvested RSUs shall remain outstanding and eligible to vest through the four-year anniversary of the grant date (the "Second Vesting Date"), with the measurement period extended to the Second Vesting Date.

Remarks:

This Form 4 is being filed late due to unanticipated delays in receiving the Reporting Person's EDGAR codes, which delays we understand were due to the high volume of applications at the time.

	/s/ Julie Szeker, attorney-in-fact	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Lumexa Imaging (LMRI) disclose in this Form 4?

The company disclosed that its Chief Financial Officer, Martin James Anthony, was awarded two grants of common-stock-based compensation totaling 54,054 restricted stock units (RSUs) on December 12, 2025.

How many Lumexa Imaging (LMRI) shares were granted to the CFO and at what price?

The CFO received 27,027 RSUs in one grant and another 27,027 RSUs in a second grant, for a total of 54,054 RSUs, each with a grant price of $0 per share as reported.

What is the time-based vesting schedule for the CFOs RSUs at Lumexa Imaging (LMRI)?

One RSU grant will vest in three substantially equal annual installments on each of the first three anniversaries of the grant date, provided the CFO continues to serve at the company.

What stock price targets affect vesting of the performance RSUs at Lumexa Imaging (LMRI)?

The performance RSUs vest in three equal installments upon achieving volume-weighted average price targets of $27.00, $36.00 and $45.00 per share over any 60 trading day period within the specified measurement window.

Over what period can Lumexa Imaging (LMRI) performance RSUs vest for the CFO?

The stock price targets are measured from the first business day after the 180-day lock-up period ends until the three-year anniversary of the grant date, with any unachieved targets remaining eligible to vest through the four-year anniversary of the grant date.

Is the Lumexa Imaging (LMRI) Form 4 related to a sale or a purchase by the CFO?

The Form 4 reports acquisitions of RSUs by the CFO as equity compensation at a stated price of $0 per share; it does not report any share sales.